Tag Archives: Auristatin F

31Jul/22

About ADCs Payloads: Microtubule-destroying Drug

July 31, 2022ReviewADCs Payloads, Auristatin F, DM4, Microtubule-destroying drugsbioadc

Antibody-drug conjugate (ADC) is formed by linking monoclonal antibodies targeting specific antigens with small molecular cytotoxic drugs through linkers, which have both the strong killing effect of traditional small molecule chemotherapy andRead More…

03Apr/19

BCMA targeted therapy! GSK antibody drug conjugates apply for sale at the end of the year

April 3, 2019Antibody-drug Conjugates ResearchADC, Auristatin F, BCMA, GSK2857916bioadc

British pharmaceutical company GlaxoSmithKline (GSK) recently announced the clinical study DREAMM -1 (NCT02064387) further positive data of experimental anti-B cell mature antigen (BCMA) antibody drug conjugate (ADC) GSK2857916 in the treatment ofRead More…

Home
Antibody-drug Conjugates Research
Antibody-drug Conjugates Manufacturing
News